Hormone replacement therapy (HRT) does not increase breast cancer risk in BRCA1/BRCA2 carriers, with estrogen-alone formulations showing a lower risk. The study used a matched-pair design to control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback